McKenzie Kathryn B 4
4 · NEOGENOMICS INC · Filed Dec 30, 2021
Insider Transaction Report
Form 4
McKenzie Kathryn B
Principal Accounting Officer
Transactions
- Award
Common Stock
2021-12-30+30,572→ 47,261 total
Holdings
- 20,000
Stock Option (Right to Buy)
Exercise: $9.07Exp: 2022-10-18→ Common Stock (20,000 underlying) - 13,894
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (13,894 underlying) - 35,171
Stock Option (Right to Buy)
Exercise: $53.17Exp: 2028-03-02→ Common Stock (35,171 underlying) - 40,000
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (40,000 underlying) - 37,514
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (37,514 underlying)
Footnotes (6)
- [F1]On December 30, 2021, Ms. McKenzie was granted 30,572 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.
- [F2]On October 17, 2017, Ms. McKenzie was granted 25,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F3]On February 26, 2018, Ms. McKenzie was granted 48,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Ms. McKenzie was granted 13,894 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Ms. McKenzie was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F6]On March 2, 2021, Ms. McKenzie was granted 35,171 stock options. These options vest ratably over the first four anniversary dates of the grant date.